Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
544759-BOM
544759-BOM

Goldline Pharmaceutical Ltd.

BSE: 544759
SME
Sector: Healthcare
Industry: Pharmaceuticals
30.10+0.1 (+0.40%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
28.90
P/E (TTM)
7.02
P/B
2.03
P/S (TTM)
0.93
EV/EBITDA
5.40
CAPE (5Y)
-
ROE (TTM)
33.47
ROCE (TTM)
29.91
ROA (TTM)
14.93
Avg 3Y ROE
30.27
Earnings 3Y CAGR
152.22
Sales 3Y CAGR
16.27
Sales 5Y CAGR
-
Debt/Equity
0.64
Consensus TP
-
Strong Buy %
-
Promoter Holding
59.54
Pledged %
0.00

Share Price

Track Goldline Pharmaceutical Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -7.33 %
Low
28.1
High
32.0
1 Month returns: -8.51 %
Low
28.1
High
34.8
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Goldline Pharmaceutical Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Goldline Pharmaceutical Ltd. Shareholding Pattern

Quarterly breakdown of Goldline Pharmaceutical Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Goldline Pharmaceutical Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Goldline Pharmaceutical Ltd.?
The current share price of Goldline Pharmaceutical Ltd. is ₹ 30.10 as of 23 Oct 2026.
What is the market capitalisation of Goldline Pharmaceutical Ltd.?
The market capitalisation of Goldline Pharmaceutical Ltd. stands at ₹ 28.90 Cr.
What is the PE ratio of Goldline Pharmaceutical Ltd.?
The Price-to-Earnings (PE) ratio of Goldline Pharmaceutical Ltd. is 7.02 as of the latest trailing twelve months data.
What is the ROE and ROCE of Goldline Pharmaceutical Ltd.?
Goldline Pharmaceutical Ltd. has a Return on Equity (ROE) of 33.47% and a Return on Capital Employed (ROCE) of 29.91% as per the latest financial reports.
What is the 52-week high and low of Goldline Pharmaceutical Ltd.?
The 52-week high of Goldline Pharmaceutical Ltd. is - and the 52-week low is -.
What is the dividend yield of Goldline Pharmaceutical Ltd.?
The dividend yield of Goldline Pharmaceutical Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Goldline Pharmaceutical Ltd.?
Foreign Institutional Investors (FII) hold 0.31%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 37.60% of Goldline Pharmaceutical Ltd. shares.
What sector does Goldline Pharmaceutical Ltd. belong to?
Goldline Pharmaceutical Ltd. operates in the Healthcare sector.
What is the beta of Goldline Pharmaceutical Ltd.?
The beta of Goldline Pharmaceutical Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Goldline Pharmaceutical Ltd.?
The 14-day Relative Strength Index (RSI) of Goldline Pharmaceutical Ltd. is 34.61, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.